- Home
- >
- Investors
Presentation
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Adocia is a French clinical-stage biotech company. The core activities of the company are to innovate, to discover and to develop new therapeutic solutions to improve the lives of people suffering from chronic metabolic diseases, such as diabetes and obesity.
ADOCIAADOC.PA
7,05%5,80 €
Source: Forex
Latest press releases
ADOCIA and Tonghua Dongbao Announce the Final Dosing in a Phase 3 Clinical Study of BioChaperone® Lispro, Milestone Associated with a $10 Million Payment
12/12/2024
ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update
10/30/2024
ADOCIA announces patenting stable combinations of GLP-1 and amylin analogs for the treatment of obesity and diabetes using its BioChaperone® platform
10/15/2024
